Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Immunosuppressive Agents (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Immunosuppressive Agents (administration & dosage) < Immunosuppressive Agents (adverse effects) < Immunosuppressive Agents (pharmacokinetics)  Facettes :

List of bibliographic references indexed by Immunosuppressive Agents (adverse effects)

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000C17 (2018) Oded Breuer [Australie] ; André Schultz [Australie]Side effects of medications used to treat childhood interstitial lung disease.
000C42 (2018) Anthony M. Lamattina [États-Unis] ; Angelo Taveira-Dasilva [États-Unis] ; Hilary J. Goldberg [États-Unis] ; Shefali Bagwe [États-Unis] ; Ye Cui [États-Unis] ; Ivan O. Rosas [États-Unis] ; Joel Moss [États-Unis] ; Elizabeth P. Henske [États-Unis] ; Souheil El-Chemaly [États-Unis]Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis.
000D22 (2017) Chung-Yuan Hsu ; Ming-Shyan Lin ; Yu-Jih Su ; Tien-Tsai Cheng ; Yu-Sheng Lin ; Ying-Chou Chen ; Wen-Chan Chiu ; Tien-Hsing Chen [Taïwan]Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study.
001307 (2012) M. Aringer [Allemagne] ; H. Burkhardt ; G R Burmester ; R. Fischer-Betz ; M. Fleck ; W. Graninger ; F. Hiepe ; A M Jacobi ; I. Kötter ; H J Lakomek ; H M Lorenz ; B. Manger ; G. Schett ; R E Schmidt ; M. Schneider ; H. Schulze-Koops ; J S Smolen ; C. Specker ; T. Stoll ; A. Strangfeld ; H P Tony ; P M Villiger ; R. Voll ; T. Witte ; T. DörnerCurrent state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.
001617 (2010) Keith C. Meyer [États-Unis] ; Catherine Decker ; Robert BaughmanToxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases.
001C13 (2006) S. Paramothayan ; T J Lasserson ; E H WaltersImmunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
002038 (2003) S. Paramothayan ; T. Lasserson ; E H WaltersImmunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
002717 (1998) N G Singer [États-Unis] ; W J MccuneUpdate on immunosuppressive therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Immunosuppressive Agents (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Immunosuppressive Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Immunosuppressive Agents (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021